Loading...
Loading...
BIOLASE, Inc.
BIOL, the world's leading manufacturer and distributor of dental
lasers, and a pioneer in laser surgery in other medical specialties,
announced today that the U.S. Patent and Trademark Office ("USPTO")
has issued BIOLASE(R) a new patent for delivering sterile water. This
new patent significantly expands on BIOLASE's fluid conditioning
system technology which is already covered in several issued U.S.
patents. Currently, BIOLASE holds over 180 issued patents in the
field of medical and dental laser technology, with several new patent
applications pending world-wide.
U.S. Patent No. 8,485,818 is titled "Fluid Controller" and relates to
a new controlled way of delivering sterile water within the fluid
conditioning system of BIOLASE's revolutionary WaterLase(R) systems.
This technology will be used in both dental and medical cutting,
irrigating, evacuating, cleaning and drilling operations. An additional important aspect of this new patent is the introduction of
disinfectant agents via spray, mist, or water stream used for dental
or surgical applications.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In: News
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in